image
Takeda Pharmaceutical Company Limited TAK
Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - JP
Watchlist
$ 13.62
0.368 %
$ 43.2 B
Market Cap
23.08
P/E
CASH FLOW STATEMENT
640 B OPERATING CASH FLOW
-34.47%
Growth Rates
1Year -34.47%
3Years -14.12%
5Years 14.28%
7Years 13.66%
10Years 15.75%
-464 B INVESTING CASH FLOW
23.59%
Growth Rates
1Year 23.59%
3Years -29.64%
5Years 30.38%
7Years 4.82%
10Years -11.33%
-354 B FINANCING CASH FLOW
50.02%
Growth Rates
1Year 50.02%
3Years 31.20%
5Years -2.30%
7Years -12.09%
10Years -16.21%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Takeda Pharmaceutical Company Limited
image
Net Income 144 B
Depreciation & Amortization 728 B
Capital Expenditures -481 B
Stock-Based Compensation 70.9 B
Change in Working Capital -256 B
Others -24.7 B
Free Cash Flow 160 B

Cash Flow

Millions
Mar-2024 Mar-2023 Mar-2022 Mar-2021 Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016 Mar-2015 Mar-2014 Mar-2013 Mar-2012 Mar-2011 Mar-2010 Mar-2009 Mar-2008 Mar-2007 Mar-2006 Mar-2005 Mar-2004 Mar-2003 Mar-2002 Mar-2001 Mar-2000
OPERATING CASH FLOW
Net Income 144 067.0 317 038.0 230 166.0 376 171.0 44 290.0 109 014.0 186 708.0 115 513.0 83 480.0 (143 034.0) 109 558.0 129 707.0 252 478.0 371 572.0 415 829.0 398 546.0 576 842.0 625 379.0 517 957.0 441 102.0 446 144.0 431 898.0 235 656.0 263 076.0 119 625.0
Depreciation & Amortization 728 002.0 664 400.0 583 151.0 559 671.0 583 649.0 272 446.0 182 127.0 222 787.0 197 381.0 260 951.0 215 743.0 201 106.0 150 194.0 106 722.0 114 825.0 118 081.0 31 690.0 28 820.0 28 728.0 31 226.0 28 083.0 29 962.0 28 430.0 33 605.0 33 364.0
Deferred Income Tax (91 406.0) 58 052.0 72 405.0 (9 936.0) (105 044.0) (14 118.0) 30 497.0 27 833.0 37 059.0 (2 403.0) 49 292.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Based Compensation 70 871.0 60 672.0 43 374.0 37 663.0 29 122.0 20 084.0 18 610.0 17 414.0 14 714.0 20 350.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Operating Activities 120 813.0 (97 742.0) 95 404.0 (228 419.0) 23 063.0 (134 893.0) (53 492.0) 25 488.0 22 096.0 (80 021.0) 44 636.0 (35 433.0) (130 827.0) (142 196.0) (163 634.0) (153 437.0) (307 326.0) (409 060.0) (163 096.0) (148 177.0) (146 843.0) (205 132.0) (27 748.0) (48 977.0) 11 386.0
Change in Working Capital (256 003.0) (25 264.0) 98 605.0 275 781.0 94 672.0 75 946.0 13 404.0 29 675.0 (267 213.0) 262 326.0 (57 117.0) 12 329.0 64 725.0 (9 160.0) 14 148.0 (36 917.0) (8 711.0) (35 859.0) (10 014.0) (28 612.0) (16 262.0) 6 721.0 4 248.0 (35 042.0) (5 413.0)
Cash From Operations 716 344.0 977 156.0 1 123 105.0 1 010 931.0 669 752.0 328 479.0 377 854.0 261 363.0 25 491.0 182 517.0 148 335.0 307 709.0 336 570.0 326 938.0 381 168.0 326 273.0 292 495.0 209 280.0 373 575.0 295 539.0 311 122.0 263 449.0 240 586.0 212 662.0 158 962.0
INVESTING CASH FLOW
Capital Expenditures (480 730.0) (633 689.0) (186 037.0) (236 468.0) (217 710.0) (134 114.0) (128 262.0) (112 027.0) (84 857.0) (108 718.0) (78 519.0) (95 763.0) (61 904.0) (124 165.0) (86 960.0) (39 464.0) (32 618.0) (29 151.0) (32 093.0) (53 669.0) (54 160.0) (33 477.0) (37 523.0) (26 941.0) (35 423.0)
Other Items 16 868.0 26 587.0 (12 088.0) 629 998.0 509 829.0 (2 701 584.0) 34 920.0 (543 664.0) 13 649.0 200 065.0 (80 092.0) (15 613.0) (1 032 060.0) 24 910.0 (30 561.0) (727 792.0) 134 367.0 145 543.0 38 659.0 (18 636.0) (85 162.0) 173 625.0 162 762.0 (31 308.0) (16 252.0)
Cash From Investing Activities (463 862.0) (607 102.0) (198 125.0) 393 530.0 292 119.0 (2 835 698.0) (93 342.0) (655 691.0) (71 208.0) 91 347.0 (158 611.0) (111 376.0) (1 093 964.0) (99 255.0) (117 521.0) (767 256.0) 101 749.0 116 392.0 6 566.0 (72 305.0) (139 322.0) 140 148.0 125 239.0 (58 249.0) (51 675.0)
FINANCING CASH FLOW
Common Stock Repurchased (2 326.0) (26 929.0) (77 531.0) (2 141.0) (3 737.0) (1 172.0) (18 756.0) (23 117.0) (22 346.0) (17 587.0) (37.0) (24.0) (16.0) (50.0) (34.0) (280 268.0) (128 758.0) (213 734.0) (156.0) (166.0) 0 0 0 0 0
Total Debt Repaid 1 513.0 (325 071.0) (600 475.0) (660 504.0) (234 867.0) 3 161 504.0 (153 136.0) 471 421.0 45 922.0 (119 493.0) 248 897.0 (4 863.0) 539 297.0 (663.0) (1 137.0) (170.0) (2 187.0) (1 888.0) (2 252.0) 2 699.0 2 524.0 (2 048.0) (1 994.0) (4 937.0) 1 108.0
Dividends Paid (287 188.0) (279 416.0) (283 665.0) (283 357.0) (282 582.0) (142 952.0) (141 893.0) (141 688.0) (141 538.0) (141 637.0) (142 133.0) (142 118.0) (142 013.0) (142 055.0) (143 554.0) (142 446.0) (129 167.0) (98 757.0) (85 529.0) (74 958.0) (60 869.0) (54 435.0) (48 541.0) (36 610.0) (28 009.0)
Other Financing Activities (66 415.0) (77 732.0) (108 594.0) (142 352.0) (484 027.0) (71 143.0) (12 441.0) (16 720.0) (6 877.0) (22 281.0) (5 323.0) (5 197.0) (3 479.0) (3 776.0) (3 321.0) (2 956.0) (1 970.0) (1 563.0) (1 353.0) (1 487.0) (999.0) (2 507.0) (2 123.0) (363.0) (1 006.0)
Cash From Financing Activities (354 416.0) (709 148.0) (1 070 265.0) (1 088 354.0) (1 005 213.0) 2 946 237.0 (326 226.0) 289 896.0 (124 839.0) (300 998.0) 101 441.0 (150 559.0) 393 789.0 (146 544.0) (148 046.0) (425 840.0) (262 082.0) (315 942.0) (89 290.0) (73 912.0) (59 344.0) (58 990.0) (52 658.0) (41 910.0) (27 907.0)
CHANGE IN CASH
Net Change In Cash (75 730.0) (316 165.0) (116 527.0) 328 608.0 (65 108.0) 407 120.0 (46 730.0) (131 971.0) (203 817.0) (10 805.0) 120 468.0 91 333.0 (418 463.0) 20 230.0 94 398.0 (855 158.0) (34 454.0) 21 459.0 361 911.0 188 240.0 53 126.0 324 642.0 336 641.0 119 757.0 77 957.0
FREE CASH FLOW
Free Cash Flow 159 591.0 343 467.0 937 068.0 774 463.0 452 042.0 194 365.0 249 592.0 149 336.0 (59 366.0) 73 799.0 69 816.0 211 946.0 274 666.0 202 773.0 294 208.0 286 809.0 259 877.0 180 129.0 341 482.0 241 870.0 256 962.0 229 972.0 203 063.0 185 721.0 123 539.0